In spite of current guidelines and diabetes technology such as insulin pump therapy and continuous glucose monitoring, avoiding exercise related dysglycaemia remains a challenge for many individuals with type 1 diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.